Pasireotide: A new option for treatment of acromegaly
Acromegaly is characterized by excess production of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Although surgery is the first treatment option, somatostatin receptor analogs (SSRAs) can be used in selected cases which surgery is contraindicated. A patient who has been diagnosed as...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Society of Turaz Bilim
2020-06-01
|
| Edice: | Medicine Science |
| Témata: | |
| On-line přístup: | http://www.ejmanager.com/fulltextpdf.php?mno=102548 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|